Holen Sie sich die Stockscreener-App
4.30
2.93%
-0.13
Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.60%
0.7748
|
0.7069 | 0.6135 | 0.9833 | 1.0092 |
| Interest Income/Expense |
42.26%
0.00181
|
0.00314 | 0.00443 | 0.00105 | 0.00415 |
| Operating Income/Loss |
9.60%
-0.7748
|
-0.7069 | -0.6135 | -0.9833 | -1.0092 |
| Income/Loss From Continuing Operations Before Tax |
9.32%
-0.7757
|
-0.7096 | -0.6177 | -0.986 | -1.0109 |
| Income/Loss From Continuing Operations After Tax |
9.32%
-0.7757
|
-0.7096 | -0.6177 | -0.986 | -1.0109 |
|
Net Income/Loss
|
9.32%
-0.7757
|
-0.7096 | -0.6177 | -0.986 | -1.0109 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.08%
2.7205
|
2.4715 | - | 2.2493 | 2.2493 |
| Diluted Average Shares |
10.08%
2.7205
|
2.4715 | - | 2.2493 | 2.2493 |
| Basic Earnings Per Share |
0.00%
-0.29
|
-0.29 | -0.27 | -0.44 | -0.45 |
| Diluted Earnings Per Share |
0.00%
-0.29
|
-0.29 | -0.27 | -0.44 | -0.45 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.21%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):